Hematologic Malignancy
Lymphomatoid Papulosis
CI-CAN-00001105Explore in graph →
HematologicNon-malignant3 active trials
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001105Explore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03409432 | Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma | completed | Phase 2 | 26 | John ReneauOTHER | 1 | Aug 13, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 13, 2026source: clinicaltrials